SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001171843-23-004058
Filing Date
2023-06-21
Accepted
2023-06-21 16:50:17
Documents
13
Period of Report
2023-06-14
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K f8k_062123.htm   iXBRL 8-K 44325
2 EXHIBIT 10.1 exh_101.htm EX-10.1 158814
  Complete submission text file 0001171843-23-004058.txt   412986

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE anik-20230614.xsd EX-101.SCH 2935
4 XBRL LABEL FILE anik-20230614_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE anik-20230614_pre.xml EX-101.PRE 22343
7 EXTRACTED XBRL INSTANCE DOCUMENT f8k_062123_htm.xml XML 3486
Mailing Address 32 WIGGINS AVENUE BEDFORD MA 01730
Business Address 32 WIGGINS AVENUE BEDFORD MA 01730 (781) 457-9000
Anika Therapeutics, Inc. (Filer) CIK: 0000898437 (see all company filings)

IRS No.: 043145961 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14027 | Film No.: 231030543
SIC: 3841 Surgical & Medical Instruments & Apparatus